UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
Fusion Protein:AXIN1-DNMT3A |
Fusion Protein Summary |
Fusion gene summary |
Fusion partner gene information | Fusion gene name: AXIN1-DNMT3A | FusionPDB ID: 8555 | FusionGDB2.0 ID: 8555 | Hgene | Tgene | Gene symbol | AXIN1 | DNMT3A | Gene ID | 8312 | 1788 |
Gene name | axin 1 | DNA methyltransferase 3 alpha | |
Synonyms | AXIN|PPP1R49 | DNMT3A2|HESJAS|M.HsaIIIA|TBRS | |
Cytomap | 16p13.3 | 2p23.3 | |
Type of gene | protein-coding | protein-coding | |
Description | axin-1axis inhibition protein 1axis inhibitor 1fused, mouse, homolog ofprotein phosphatase 1, regulatory subunit 49 | DNA (cytosine-5)-methyltransferase 3ADNA (cytosine-5-)-methyltransferase 3 alphaDNA MTase HsaIIIADNA cytosine methyltransferase 3A2 | |
Modification date | 20200322 | 20200322 | |
UniProtAcc | O15169 | Q9Y6K1 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000262320, ENST00000354866, ENST00000481769, | ENST00000380746, ENST00000402667, ENST00000474887, ENST00000264709, ENST00000321117, ENST00000406659, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 16 X 10 X 9=1440 | 4 X 4 X 3=48 |
# samples | 23 | 4 | |
** MAII score | log2(23/1440*10)=-2.6463630453853 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(4/48*10)=-0.263034405833794 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: AXIN1 [Title/Abstract] AND DNMT3A [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | AXIN1(354303)-DNMT3A(25523112), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | AXIN1-DNMT3A seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. AXIN1-DNMT3A seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. AXIN1-DNMT3A seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. AXIN1-DNMT3A seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | AXIN1 | GO:0001934 | positive regulation of protein phosphorylation | 9601641 |
Hgene | AXIN1 | GO:0032147 | activation of protein kinase activity | 9601641 |
Hgene | AXIN1 | GO:0034622 | cellular protein-containing complex assembly | 16601693 |
Hgene | AXIN1 | GO:0045732 | positive regulation of protein catabolic process | 9601641 |
Hgene | AXIN1 | GO:0090090 | negative regulation of canonical Wnt signaling pathway | 10644691 |
Tgene | DNMT3A | GO:0006306 | DNA methylation | 12138111|19786833|23042785 |
Fusion gene breakpoints across AXIN1 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across DNMT3A (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Top |
Fusion Gene Sample Information |
Fusion gene information from FusionGDB2.0. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | STAD | TCGA-BR-8686 | AXIN1 | chr16 | 354303 | - | DNMT3A | chr2 | 25523112 | - |
Top |
Fusion ORF Analysis |
Fusion information from ORFfinder translation from full-length transcript sequence from FusionPDB. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000262320 | AXIN1 | chr16 | 354303 | - | ENST00000321117 | DNMT3A | chr2 | 25523112 | - | 5596 | 1626 | 21 | 4292 | 1423 |
ENST00000262320 | AXIN1 | chr16 | 354303 | - | ENST00000264709 | DNMT3A | chr2 | 25523112 | - | 5596 | 1626 | 21 | 4292 | 1423 |
ENST00000262320 | AXIN1 | chr16 | 354303 | - | ENST00000406659 | DNMT3A | chr2 | 25523112 | - | 2991 | 1626 | 21 | 2054 | 677 |
ENST00000354866 | AXIN1 | chr16 | 354303 | - | ENST00000321117 | DNMT3A | chr2 | 25523112 | - | 5386 | 1416 | 15 | 4082 | 1355 |
ENST00000354866 | AXIN1 | chr16 | 354303 | - | ENST00000264709 | DNMT3A | chr2 | 25523112 | - | 5386 | 1416 | 15 | 4082 | 1355 |
ENST00000354866 | AXIN1 | chr16 | 354303 | - | ENST00000406659 | DNMT3A | chr2 | 25523112 | - | 2781 | 1416 | 15 | 1844 | 609 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000262320 | ENST00000321117 | AXIN1 | chr16 | 354303 | - | DNMT3A | chr2 | 25523112 | - | 0.000880562 | 0.99911946 |
ENST00000262320 | ENST00000264709 | AXIN1 | chr16 | 354303 | - | DNMT3A | chr2 | 25523112 | - | 0.000880562 | 0.99911946 |
ENST00000262320 | ENST00000406659 | AXIN1 | chr16 | 354303 | - | DNMT3A | chr2 | 25523112 | - | 0.008465235 | 0.99153477 |
ENST00000354866 | ENST00000321117 | AXIN1 | chr16 | 354303 | - | DNMT3A | chr2 | 25523112 | - | 0.000631129 | 0.99936885 |
ENST00000354866 | ENST00000264709 | AXIN1 | chr16 | 354303 | - | DNMT3A | chr2 | 25523112 | - | 0.000631129 | 0.99936885 |
ENST00000354866 | ENST00000406659 | AXIN1 | chr16 | 354303 | - | DNMT3A | chr2 | 25523112 | - | 0.006864031 | 0.9931359 |
Top |
Fusion Amino Acid Sequences |
For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >8555_8555_1_AXIN1-DNMT3A_AXIN1_chr16_354303_ENST00000262320_DNMT3A_chr2_25523112_ENST00000264709_length(amino acids)=1423AA_BP=535 MPPPEPAGVGPEPRPRGAGGWELAAGPLRRPRGLPRVRLRAAEPQPPRWGPPRAAPPPGPARRAAAERMGPDRAAPLREPGPGSRHHRAR DRLIHFGAVSTDVLGCSAHCSLTQSPKMNIQEQGFPLDLGASFTEDAPRPPVPGEEGELVSTDPRPASYSFCSGKGVGIKGETSTATPRR SDLDLGYEPEGSASPTPPYLKWAESLHSLLDDQDGISLFRTFLKQEGCADLLDFWFACTGFRKLEPCDSNEEKRLKLARAIYRKYILDNN GIVSRQTKPATKSFIKGCIMKQLIDPAMFDQAQTEIQATMEENTYPSFLKSDIYLEYTRTGSESPKVCSDQSSGSGTGKGISGYLPTLNE DEEWKCDQDMDEDDGRDAAPPGRLPQKLLLETAAPRVSSSRRYSEGREFRYGSWREPVNPYYVNAGYALAPATSANDSEQQSLSSDADTL SLTDSSVDGIPPYRIRKQHRREMQESVQVNGRVPLPHIPRTYRVPKEVRVEPQKFAEELIHRLEAVQRTREAEEKLEERLKRVRMDGEEQ EEPRGKEERQEPSTTARKVGRPGRKRKHPPVESGDTPKDPAVISKSPSMAQDSGASELLPNGDLEKRSEPQPEEGSPAGGQKGGAPAEGE GAAETLPEASRAVENGCCTPKEGRGAPAEAGKEQKETNIESMKMEGSRGRLRGGLGWESSLRQRPMPRLTFQAGDPYYISKRKRDEWLAR WKREAEKKAKVIAGMNAVEENQGPGESQKVEEASPPAVQQPTDPASPTVATTPEPVGSDAGDKNATKAGDDEPEYEDGRGFGIGELVWGK LRGFSWWPGRIVSWWMTGRSRAAEGTRWVMWFGDGKFSVVCVEKLMPLSSFCSAFHQATYNKQPMYRKAIYEVLQVASSRAGKLFPVCHD SDESDTAKAVEVQNKPMIEWALGGFQPSGPKGLEPPEEEKNPYKEVYTDMWVEPEAAAYAPPPPAKKPRKSTAEKPKVKEIIDERTRERL VYEVRQKCRNIEDICISCGSLNVTLEHPLFVGGMCQNCKNCFLECAYQYDDDGYQSYCTICCGGREVLMCGNNNCCRCFCVECVDLLVGP GAAQAAIKEDPWNCYMCGHKGTYGLLRRREDWPSRLQMFFANNHDQEFDPPKVYPPVPAEKRKPIRVLSLFDGIATGLLVLKDLGIQVDR YIASEVCEDSITVGMVRHQGKIMYVGDVRSVTQKHIQEWGPFDLVIGGSPCNDLSIVNPARKGLYEGTGRLFFEFYRLLHDARPKEGDDR PFFWLFENVVAMGVSDKRDISRFLESNPVMIDAKEVSAAHRARYFWGNLPGMNRPLASTVNDKLELQECLEHGRIAKFSKVRTITTRSNS -------------------------------------------------------------- >8555_8555_2_AXIN1-DNMT3A_AXIN1_chr16_354303_ENST00000262320_DNMT3A_chr2_25523112_ENST00000321117_length(amino acids)=1423AA_BP=535 MPPPEPAGVGPEPRPRGAGGWELAAGPLRRPRGLPRVRLRAAEPQPPRWGPPRAAPPPGPARRAAAERMGPDRAAPLREPGPGSRHHRAR DRLIHFGAVSTDVLGCSAHCSLTQSPKMNIQEQGFPLDLGASFTEDAPRPPVPGEEGELVSTDPRPASYSFCSGKGVGIKGETSTATPRR SDLDLGYEPEGSASPTPPYLKWAESLHSLLDDQDGISLFRTFLKQEGCADLLDFWFACTGFRKLEPCDSNEEKRLKLARAIYRKYILDNN GIVSRQTKPATKSFIKGCIMKQLIDPAMFDQAQTEIQATMEENTYPSFLKSDIYLEYTRTGSESPKVCSDQSSGSGTGKGISGYLPTLNE DEEWKCDQDMDEDDGRDAAPPGRLPQKLLLETAAPRVSSSRRYSEGREFRYGSWREPVNPYYVNAGYALAPATSANDSEQQSLSSDADTL SLTDSSVDGIPPYRIRKQHRREMQESVQVNGRVPLPHIPRTYRVPKEVRVEPQKFAEELIHRLEAVQRTREAEEKLEERLKRVRMDGEEQ EEPRGKEERQEPSTTARKVGRPGRKRKHPPVESGDTPKDPAVISKSPSMAQDSGASELLPNGDLEKRSEPQPEEGSPAGGQKGGAPAEGE GAAETLPEASRAVENGCCTPKEGRGAPAEAGKEQKETNIESMKMEGSRGRLRGGLGWESSLRQRPMPRLTFQAGDPYYISKRKRDEWLAR WKREAEKKAKVIAGMNAVEENQGPGESQKVEEASPPAVQQPTDPASPTVATTPEPVGSDAGDKNATKAGDDEPEYEDGRGFGIGELVWGK LRGFSWWPGRIVSWWMTGRSRAAEGTRWVMWFGDGKFSVVCVEKLMPLSSFCSAFHQATYNKQPMYRKAIYEVLQVASSRAGKLFPVCHD SDESDTAKAVEVQNKPMIEWALGGFQPSGPKGLEPPEEEKNPYKEVYTDMWVEPEAAAYAPPPPAKKPRKSTAEKPKVKEIIDERTRERL VYEVRQKCRNIEDICISCGSLNVTLEHPLFVGGMCQNCKNCFLECAYQYDDDGYQSYCTICCGGREVLMCGNNNCCRCFCVECVDLLVGP GAAQAAIKEDPWNCYMCGHKGTYGLLRRREDWPSRLQMFFANNHDQEFDPPKVYPPVPAEKRKPIRVLSLFDGIATGLLVLKDLGIQVDR YIASEVCEDSITVGMVRHQGKIMYVGDVRSVTQKHIQEWGPFDLVIGGSPCNDLSIVNPARKGLYEGTGRLFFEFYRLLHDARPKEGDDR PFFWLFENVVAMGVSDKRDISRFLESNPVMIDAKEVSAAHRARYFWGNLPGMNRPLASTVNDKLELQECLEHGRIAKFSKVRTITTRSNS -------------------------------------------------------------- >8555_8555_3_AXIN1-DNMT3A_AXIN1_chr16_354303_ENST00000262320_DNMT3A_chr2_25523112_ENST00000406659_length(amino acids)=677AA_BP=535 MPPPEPAGVGPEPRPRGAGGWELAAGPLRRPRGLPRVRLRAAEPQPPRWGPPRAAPPPGPARRAAAERMGPDRAAPLREPGPGSRHHRAR DRLIHFGAVSTDVLGCSAHCSLTQSPKMNIQEQGFPLDLGASFTEDAPRPPVPGEEGELVSTDPRPASYSFCSGKGVGIKGETSTATPRR SDLDLGYEPEGSASPTPPYLKWAESLHSLLDDQDGISLFRTFLKQEGCADLLDFWFACTGFRKLEPCDSNEEKRLKLARAIYRKYILDNN GIVSRQTKPATKSFIKGCIMKQLIDPAMFDQAQTEIQATMEENTYPSFLKSDIYLEYTRTGSESPKVCSDQSSGSGTGKGISGYLPTLNE DEEWKCDQDMDEDDGRDAAPPGRLPQKLLLETAAPRVSSSRRYSEGREFRYGSWREPVNPYYVNAGYALAPATSANDSEQQSLSSDADTL SLTDSSVDGIPPYRIRKQHRREMQESVQVNGRVPLPHIPRTYRVPKEVRVEPQKFAEELIHRLEAVQRTREAEEKLEERLKRVRMDGEEQ EEPRGKEERQEPSTTARKVGRPGRKRKHPPVESGDTPKDPAVISKSPSMAQDSGASELLPNGDLEKRSEPQPEEGSPAGGQKGGAPAEGE -------------------------------------------------------------- >8555_8555_4_AXIN1-DNMT3A_AXIN1_chr16_354303_ENST00000354866_DNMT3A_chr2_25523112_ENST00000264709_length(amino acids)=1355AA_BP=467 MGPDRAAPLREPGPGSRHHRARDRLIHFGAVSTDVLGCSAHCSLTQSPKMNIQEQGFPLDLGASFTEDAPRPPVPGEEGELVSTDPRPAS YSFCSGKGVGIKGETSTATPRRSDLDLGYEPEGSASPTPPYLKWAESLHSLLDDQDGISLFRTFLKQEGCADLLDFWFACTGFRKLEPCD SNEEKRLKLARAIYRKYILDNNGIVSRQTKPATKSFIKGCIMKQLIDPAMFDQAQTEIQATMEENTYPSFLKSDIYLEYTRTGSESPKVC SDQSSGSGTGKGISGYLPTLNEDEEWKCDQDMDEDDGRDAAPPGRLPQKLLLETAAPRVSSSRRYSEGREFRYGSWREPVNPYYVNAGYA LAPATSANDSEQQSLSSDADTLSLTDSSVDGIPPYRIRKQHRREMQESVQVNGRVPLPHIPRTYRVPKEVRVEPQKFAEELIHRLEAVQR TREAEEKLEERLKRVRMDGEEQEEPRGKEERQEPSTTARKVGRPGRKRKHPPVESGDTPKDPAVISKSPSMAQDSGASELLPNGDLEKRS EPQPEEGSPAGGQKGGAPAEGEGAAETLPEASRAVENGCCTPKEGRGAPAEAGKEQKETNIESMKMEGSRGRLRGGLGWESSLRQRPMPR LTFQAGDPYYISKRKRDEWLARWKREAEKKAKVIAGMNAVEENQGPGESQKVEEASPPAVQQPTDPASPTVATTPEPVGSDAGDKNATKA GDDEPEYEDGRGFGIGELVWGKLRGFSWWPGRIVSWWMTGRSRAAEGTRWVMWFGDGKFSVVCVEKLMPLSSFCSAFHQATYNKQPMYRK AIYEVLQVASSRAGKLFPVCHDSDESDTAKAVEVQNKPMIEWALGGFQPSGPKGLEPPEEEKNPYKEVYTDMWVEPEAAAYAPPPPAKKP RKSTAEKPKVKEIIDERTRERLVYEVRQKCRNIEDICISCGSLNVTLEHPLFVGGMCQNCKNCFLECAYQYDDDGYQSYCTICCGGREVL MCGNNNCCRCFCVECVDLLVGPGAAQAAIKEDPWNCYMCGHKGTYGLLRRREDWPSRLQMFFANNHDQEFDPPKVYPPVPAEKRKPIRVL SLFDGIATGLLVLKDLGIQVDRYIASEVCEDSITVGMVRHQGKIMYVGDVRSVTQKHIQEWGPFDLVIGGSPCNDLSIVNPARKGLYEGT GRLFFEFYRLLHDARPKEGDDRPFFWLFENVVAMGVSDKRDISRFLESNPVMIDAKEVSAAHRARYFWGNLPGMNRPLASTVNDKLELQE CLEHGRIAKFSKVRTITTRSNSIKQGKDQHFPVFMNEKEDILWCTEMERVFGFPVHYTDVSNMSRLARQRLLGRSWSVPVIRHLFAPLKE -------------------------------------------------------------- >8555_8555_5_AXIN1-DNMT3A_AXIN1_chr16_354303_ENST00000354866_DNMT3A_chr2_25523112_ENST00000321117_length(amino acids)=1355AA_BP=467 MGPDRAAPLREPGPGSRHHRARDRLIHFGAVSTDVLGCSAHCSLTQSPKMNIQEQGFPLDLGASFTEDAPRPPVPGEEGELVSTDPRPAS YSFCSGKGVGIKGETSTATPRRSDLDLGYEPEGSASPTPPYLKWAESLHSLLDDQDGISLFRTFLKQEGCADLLDFWFACTGFRKLEPCD SNEEKRLKLARAIYRKYILDNNGIVSRQTKPATKSFIKGCIMKQLIDPAMFDQAQTEIQATMEENTYPSFLKSDIYLEYTRTGSESPKVC SDQSSGSGTGKGISGYLPTLNEDEEWKCDQDMDEDDGRDAAPPGRLPQKLLLETAAPRVSSSRRYSEGREFRYGSWREPVNPYYVNAGYA LAPATSANDSEQQSLSSDADTLSLTDSSVDGIPPYRIRKQHRREMQESVQVNGRVPLPHIPRTYRVPKEVRVEPQKFAEELIHRLEAVQR TREAEEKLEERLKRVRMDGEEQEEPRGKEERQEPSTTARKVGRPGRKRKHPPVESGDTPKDPAVISKSPSMAQDSGASELLPNGDLEKRS EPQPEEGSPAGGQKGGAPAEGEGAAETLPEASRAVENGCCTPKEGRGAPAEAGKEQKETNIESMKMEGSRGRLRGGLGWESSLRQRPMPR LTFQAGDPYYISKRKRDEWLARWKREAEKKAKVIAGMNAVEENQGPGESQKVEEASPPAVQQPTDPASPTVATTPEPVGSDAGDKNATKA GDDEPEYEDGRGFGIGELVWGKLRGFSWWPGRIVSWWMTGRSRAAEGTRWVMWFGDGKFSVVCVEKLMPLSSFCSAFHQATYNKQPMYRK AIYEVLQVASSRAGKLFPVCHDSDESDTAKAVEVQNKPMIEWALGGFQPSGPKGLEPPEEEKNPYKEVYTDMWVEPEAAAYAPPPPAKKP RKSTAEKPKVKEIIDERTRERLVYEVRQKCRNIEDICISCGSLNVTLEHPLFVGGMCQNCKNCFLECAYQYDDDGYQSYCTICCGGREVL MCGNNNCCRCFCVECVDLLVGPGAAQAAIKEDPWNCYMCGHKGTYGLLRRREDWPSRLQMFFANNHDQEFDPPKVYPPVPAEKRKPIRVL SLFDGIATGLLVLKDLGIQVDRYIASEVCEDSITVGMVRHQGKIMYVGDVRSVTQKHIQEWGPFDLVIGGSPCNDLSIVNPARKGLYEGT GRLFFEFYRLLHDARPKEGDDRPFFWLFENVVAMGVSDKRDISRFLESNPVMIDAKEVSAAHRARYFWGNLPGMNRPLASTVNDKLELQE CLEHGRIAKFSKVRTITTRSNSIKQGKDQHFPVFMNEKEDILWCTEMERVFGFPVHYTDVSNMSRLARQRLLGRSWSVPVIRHLFAPLKE -------------------------------------------------------------- >8555_8555_6_AXIN1-DNMT3A_AXIN1_chr16_354303_ENST00000354866_DNMT3A_chr2_25523112_ENST00000406659_length(amino acids)=609AA_BP=467 MGPDRAAPLREPGPGSRHHRARDRLIHFGAVSTDVLGCSAHCSLTQSPKMNIQEQGFPLDLGASFTEDAPRPPVPGEEGELVSTDPRPAS YSFCSGKGVGIKGETSTATPRRSDLDLGYEPEGSASPTPPYLKWAESLHSLLDDQDGISLFRTFLKQEGCADLLDFWFACTGFRKLEPCD SNEEKRLKLARAIYRKYILDNNGIVSRQTKPATKSFIKGCIMKQLIDPAMFDQAQTEIQATMEENTYPSFLKSDIYLEYTRTGSESPKVC SDQSSGSGTGKGISGYLPTLNEDEEWKCDQDMDEDDGRDAAPPGRLPQKLLLETAAPRVSSSRRYSEGREFRYGSWREPVNPYYVNAGYA LAPATSANDSEQQSLSSDADTLSLTDSSVDGIPPYRIRKQHRREMQESVQVNGRVPLPHIPRTYRVPKEVRVEPQKFAEELIHRLEAVQR TREAEEKLEERLKRVRMDGEEQEEPRGKEERQEPSTTARKVGRPGRKRKHPPVESGDTPKDPAVISKSPSMAQDSGASELLPNGDLEKRS -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr16:354303/chr2:25523112) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
AXIN1 | DNMT3A |
FUNCTION: Component of the beta-catenin destruction complex required for regulating CTNNB1 levels through phosphorylation and ubiquitination, and modulating Wnt-signaling (PubMed:12192039, PubMed:27098453). Controls dorsoventral patterning via two opposing effects; down-regulates CTNNB1 to inhibit the Wnt signaling pathway and ventralize embryos, but also dorsalizes embryos by activating a Wnt-independent JNK signaling pathway (PubMed:12192039). In Wnt signaling, probably facilitates the phosphorylation of CTNNB1 and APC by GSK3B (PubMed:12192039). Likely to function as a tumor suppressor. Enhances TGF-beta signaling by recruiting the RNF111 E3 ubiquitin ligase and promoting the degradation of inhibitory SMAD7 (PubMed:16601693). Also component of the AXIN1-HIPK2-TP53 complex which controls cell growth, apoptosis and development (PubMed:17210684). Facilitates the phosphorylation of TP53 by HIPK2 upon ultraviolet irradiation (PubMed:17210684). {ECO:0000269|PubMed:12192039, ECO:0000269|PubMed:16601693, ECO:0000269|PubMed:17210684, ECO:0000269|PubMed:27098453}. | FUNCTION: Required for genome-wide de novo methylation and is essential for the establishment of DNA methylation patterns during development. DNA methylation is coordinated with methylation of histones. It modifies DNA in a non-processive manner and also methylates non-CpG sites. May preferentially methylate DNA linker between 2 nucleosomal cores and is inhibited by histone H1. Plays a role in paternal and maternal imprinting. Required for methylation of most imprinted loci in germ cells. Acts as a transcriptional corepressor for ZBTB18. Recruited to trimethylated 'Lys-36' of histone H3 (H3K36me3) sites. Can actively repress transcription through the recruitment of HDAC activity. {ECO:0000269|PubMed:16357870, ECO:0000269|PubMed:30478443}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | AXIN1 | chr16:354303 | chr2:25523112 | ENST00000262320 | - | 5 | 11 | 88_211 | 418.0 | 863.0 | Domain | RGS |
Hgene | AXIN1 | chr16:354303 | chr2:25523112 | ENST00000354866 | - | 5 | 10 | 88_211 | 418.0 | 827.0 | Domain | RGS |
Hgene | AXIN1 | chr16:354303 | chr2:25523112 | ENST00000262320 | - | 5 | 11 | 20_29 | 418.0 | 863.0 | Motif | Note=Tankyrase-binding motif |
Hgene | AXIN1 | chr16:354303 | chr2:25523112 | ENST00000354866 | - | 5 | 10 | 20_29 | 418.0 | 827.0 | Motif | Note=Tankyrase-binding motif |
Tgene | DNMT3A | chr16:354303 | chr2:25523112 | ENST00000264709 | 1 | 23 | 292_350 | 24.0 | 913.0 | Domain | PWWP | |
Tgene | DNMT3A | chr16:354303 | chr2:25523112 | ENST00000264709 | 1 | 23 | 482_614 | 24.0 | 913.0 | Domain | ADD | |
Tgene | DNMT3A | chr16:354303 | chr2:25523112 | ENST00000264709 | 1 | 23 | 634_912 | 24.0 | 913.0 | Domain | SAM-dependent MTase C5-type | |
Tgene | DNMT3A | chr16:354303 | chr2:25523112 | ENST00000321117 | 1 | 23 | 292_350 | 24.0 | 913.0 | Domain | PWWP | |
Tgene | DNMT3A | chr16:354303 | chr2:25523112 | ENST00000321117 | 1 | 23 | 482_614 | 24.0 | 913.0 | Domain | ADD | |
Tgene | DNMT3A | chr16:354303 | chr2:25523112 | ENST00000321117 | 1 | 23 | 634_912 | 24.0 | 913.0 | Domain | SAM-dependent MTase C5-type | |
Tgene | DNMT3A | chr16:354303 | chr2:25523112 | ENST00000380746 | 0 | 19 | 292_350 | 0 | 724.0 | Domain | PWWP | |
Tgene | DNMT3A | chr16:354303 | chr2:25523112 | ENST00000380746 | 0 | 19 | 482_614 | 0 | 724.0 | Domain | ADD | |
Tgene | DNMT3A | chr16:354303 | chr2:25523112 | ENST00000380746 | 0 | 19 | 634_912 | 0 | 724.0 | Domain | SAM-dependent MTase C5-type | |
Tgene | DNMT3A | chr16:354303 | chr2:25523112 | ENST00000402667 | 0 | 18 | 292_350 | 0 | 690.0 | Domain | PWWP | |
Tgene | DNMT3A | chr16:354303 | chr2:25523112 | ENST00000402667 | 0 | 18 | 482_614 | 0 | 690.0 | Domain | ADD | |
Tgene | DNMT3A | chr16:354303 | chr2:25523112 | ENST00000402667 | 0 | 18 | 634_912 | 0 | 690.0 | Domain | SAM-dependent MTase C5-type | |
Tgene | DNMT3A | chr16:354303 | chr2:25523112 | ENST00000406659 | 1 | 4 | 292_350 | 24.0 | 167.0 | Domain | PWWP | |
Tgene | DNMT3A | chr16:354303 | chr2:25523112 | ENST00000406659 | 1 | 4 | 482_614 | 24.0 | 167.0 | Domain | ADD | |
Tgene | DNMT3A | chr16:354303 | chr2:25523112 | ENST00000406659 | 1 | 4 | 634_912 | 24.0 | 167.0 | Domain | SAM-dependent MTase C5-type | |
Tgene | DNMT3A | chr16:354303 | chr2:25523112 | ENST00000264709 | 1 | 23 | 641_645 | 24.0 | 913.0 | Region | S-adenosyl-L-methionine binding | |
Tgene | DNMT3A | chr16:354303 | chr2:25523112 | ENST00000264709 | 1 | 23 | 686_688 | 24.0 | 913.0 | Region | S-adenosyl-L-methionine binding | |
Tgene | DNMT3A | chr16:354303 | chr2:25523112 | ENST00000264709 | 1 | 23 | 891_893 | 24.0 | 913.0 | Region | S-adenosyl-L-methionine binding | |
Tgene | DNMT3A | chr16:354303 | chr2:25523112 | ENST00000321117 | 1 | 23 | 641_645 | 24.0 | 913.0 | Region | S-adenosyl-L-methionine binding | |
Tgene | DNMT3A | chr16:354303 | chr2:25523112 | ENST00000321117 | 1 | 23 | 686_688 | 24.0 | 913.0 | Region | S-adenosyl-L-methionine binding | |
Tgene | DNMT3A | chr16:354303 | chr2:25523112 | ENST00000321117 | 1 | 23 | 891_893 | 24.0 | 913.0 | Region | S-adenosyl-L-methionine binding | |
Tgene | DNMT3A | chr16:354303 | chr2:25523112 | ENST00000380746 | 0 | 19 | 641_645 | 0 | 724.0 | Region | S-adenosyl-L-methionine binding | |
Tgene | DNMT3A | chr16:354303 | chr2:25523112 | ENST00000380746 | 0 | 19 | 686_688 | 0 | 724.0 | Region | S-adenosyl-L-methionine binding | |
Tgene | DNMT3A | chr16:354303 | chr2:25523112 | ENST00000380746 | 0 | 19 | 891_893 | 0 | 724.0 | Region | S-adenosyl-L-methionine binding | |
Tgene | DNMT3A | chr16:354303 | chr2:25523112 | ENST00000402667 | 0 | 18 | 641_645 | 0 | 690.0 | Region | S-adenosyl-L-methionine binding | |
Tgene | DNMT3A | chr16:354303 | chr2:25523112 | ENST00000402667 | 0 | 18 | 686_688 | 0 | 690.0 | Region | S-adenosyl-L-methionine binding | |
Tgene | DNMT3A | chr16:354303 | chr2:25523112 | ENST00000402667 | 0 | 18 | 891_893 | 0 | 690.0 | Region | S-adenosyl-L-methionine binding | |
Tgene | DNMT3A | chr16:354303 | chr2:25523112 | ENST00000406659 | 1 | 4 | 641_645 | 24.0 | 167.0 | Region | S-adenosyl-L-methionine binding | |
Tgene | DNMT3A | chr16:354303 | chr2:25523112 | ENST00000406659 | 1 | 4 | 686_688 | 24.0 | 167.0 | Region | S-adenosyl-L-methionine binding | |
Tgene | DNMT3A | chr16:354303 | chr2:25523112 | ENST00000406659 | 1 | 4 | 891_893 | 24.0 | 167.0 | Region | S-adenosyl-L-methionine binding | |
Tgene | DNMT3A | chr16:354303 | chr2:25523112 | ENST00000264709 | 1 | 23 | 493_523 | 24.0 | 913.0 | Zinc finger | GATA-type%3B atypical | |
Tgene | DNMT3A | chr16:354303 | chr2:25523112 | ENST00000264709 | 1 | 23 | 534_590 | 24.0 | 913.0 | Zinc finger | PHD-type%3B atypical | |
Tgene | DNMT3A | chr16:354303 | chr2:25523112 | ENST00000321117 | 1 | 23 | 493_523 | 24.0 | 913.0 | Zinc finger | GATA-type%3B atypical | |
Tgene | DNMT3A | chr16:354303 | chr2:25523112 | ENST00000321117 | 1 | 23 | 534_590 | 24.0 | 913.0 | Zinc finger | PHD-type%3B atypical | |
Tgene | DNMT3A | chr16:354303 | chr2:25523112 | ENST00000380746 | 0 | 19 | 493_523 | 0 | 724.0 | Zinc finger | GATA-type%3B atypical | |
Tgene | DNMT3A | chr16:354303 | chr2:25523112 | ENST00000380746 | 0 | 19 | 534_590 | 0 | 724.0 | Zinc finger | PHD-type%3B atypical | |
Tgene | DNMT3A | chr16:354303 | chr2:25523112 | ENST00000402667 | 0 | 18 | 493_523 | 0 | 690.0 | Zinc finger | GATA-type%3B atypical | |
Tgene | DNMT3A | chr16:354303 | chr2:25523112 | ENST00000402667 | 0 | 18 | 534_590 | 0 | 690.0 | Zinc finger | PHD-type%3B atypical | |
Tgene | DNMT3A | chr16:354303 | chr2:25523112 | ENST00000406659 | 1 | 4 | 493_523 | 24.0 | 167.0 | Zinc finger | GATA-type%3B atypical | |
Tgene | DNMT3A | chr16:354303 | chr2:25523112 | ENST00000406659 | 1 | 4 | 534_590 | 24.0 | 167.0 | Zinc finger | PHD-type%3B atypical |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | AXIN1 | chr16:354303 | chr2:25523112 | ENST00000262320 | - | 5 | 11 | 780_862 | 418.0 | 863.0 | Domain | DIX |
Hgene | AXIN1 | chr16:354303 | chr2:25523112 | ENST00000354866 | - | 5 | 10 | 780_862 | 418.0 | 827.0 | Domain | DIX |
Top |
Fusion Protein-Protein Interaction |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type from validated records (BIOGRID-3.4.160) |
Gene | PPI interactors |
Protein-protein interactors based on sequence similarity (STRING) |
Gene | STRING network |
AXIN1 | |
DNMT3A |
- Retained interactions in fusion protein (protein functional feature from UniProt). |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost interactions due to fusion (protein functional feature from UniProt). |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Hgene | AXIN1 | chr16:354303 | chr2:25523112 | ENST00000262320 | - | 5 | 11 | 434_502 | 418.0 | 863.0 | CTNNB1 |
Hgene | AXIN1 | chr16:354303 | chr2:25523112 | ENST00000354866 | - | 5 | 10 | 434_502 | 418.0 | 827.0 | CTNNB1 |
Hgene | AXIN1 | chr16:354303 | chr2:25523112 | ENST00000262320 | - | 5 | 11 | 348_433 | 418.0 | 863.0 | GSK3B |
Hgene | AXIN1 | chr16:354303 | chr2:25523112 | ENST00000354866 | - | 5 | 10 | 348_433 | 418.0 | 827.0 | GSK3B |
Hgene | AXIN1 | chr16:354303 | chr2:25523112 | ENST00000262320 | - | 5 | 11 | 677_752 | 418.0 | 863.0 | HIPK2 |
Hgene | AXIN1 | chr16:354303 | chr2:25523112 | ENST00000354866 | - | 5 | 10 | 677_752 | 418.0 | 827.0 | HIPK2 |
Hgene | AXIN1 | chr16:354303 | chr2:25523112 | ENST00000262320 | - | 5 | 11 | 575_789 | 418.0 | 863.0 | PPP2CA |
Hgene | AXIN1 | chr16:354303 | chr2:25523112 | ENST00000354866 | - | 5 | 10 | 575_789 | 418.0 | 827.0 | PPP2CA |
Hgene | AXIN1 | chr16:354303 | chr2:25523112 | ENST00000262320 | - | 5 | 11 | 507_757 | 418.0 | 863.0 | RNF111 |
Hgene | AXIN1 | chr16:354303 | chr2:25523112 | ENST00000354866 | - | 5 | 10 | 507_757 | 418.0 | 827.0 | RNF111 |
Top |
Related Drugs to AXIN1-DNMT3A |
Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to AXIN1-DNMT3A |
Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |